Podcasts about Rheumatology

Inflammation is an important and necessary part of the body's healing process. It's also long been a wellness buzzword used to sell products that do very little to treat it. This week, we look at inflammation through the lens of a new Mother Jones article, “The Great Inflammation Panic,” including an interview with the author, Julia Métraux, in segment two. We'll also discuss what inflammation is, how wellness influencers weaponize it, and what it represents in the context of Ayurveda. Show Notes The Great Inflammation Panic Chronic Inflammation and Cancer NIH Autoimmune Diseases Celiac Disease Cambridge press release — "Chronic diseases misdiagnosed as psychosomatic can lead to long term damage" Sloan et al., "I still can't forget those words" — Rheumatology (2025), DOI 10.1093/rheumatology/keaf115 Vasculitis diagnostic-delay data — PubMed Miranda Fricker interview — Philosophy Bites Bleuler 1911 coinage — NCBI Bookshelf, The Metamorphosis of Autism Bleuler's original 1911 text excerpt — Autism History Project Sontag, "Illness as Metaphor" — full text, NYRB Louise Hay — Natural Ways to Treat Autoimmune Disease Gabor Maté, When the Body Says No — critical review, Globe and Mail Learn more about your ad choices. Visit megaphone.fm/adchoices

Join Professor Peter Nash from the Griffith University in Brisbane; Professor Axel Finckh, from the Division of Rheumatology, Geneva University Hospitals, Geneva, Switzerland; and Bente Glintborg, an Associate Professor from the Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark as they discuss his recent paper ‘Influence of the shared epitope on the effectiveness of biologic antirheumatic agents in European patients with rheumatoid arthritis'.

What should you do when your treatment isn't working—or you're actually getting worse?In this Rheumatology 101 episode, Dr. Isabelle Amigues shares an important lesson from her clinical practice: when a treatment isn't working the way it should, sometimes the answer isn't simply increasing the medication. It's time to pause and reconsider what is really going on.Steroids such as prednisone can work quickly for many inflammatory conditions. But when symptoms don't improve as expected, or worsen despite treatment, that can be an important signal to stop and reassess.Dr. Isabelle explains why rheumatologists may need to consider whether:• The original diagnosis is correct • Another rheumatologic condition could be causing the symptoms • More than one condition is present • An infection could be contributing to symptoms • Another medical specialty should be involved • Increasing immunosuppression could potentially cause harmShe also discusses a patient whose symptoms were initially thought to be rheumatoid arthritis but were ultimately found to be related to coccidioidomycosis, a fungal infection—highlighting why doctors need to remain open-minded when a patient's response doesn't match what is expected.Most importantly, Dr. Isabelle shares what patients can ask when their doctor says, "I'm not sure."You deserve an answer, or at least a clear next step.Don't continue down a path that isn't helping you. Pause. Ask questions. Reassess. And make sure you leave with a plan for what comes next.This video is for educational purposes and is not a substitute for individualized medical advice.

This episode covers Henoch-Schönlein purpura.Notes: https://zerotofinals.com/paediatrics/rheumatology/hsp/Questions: https://members.zerotofinals.com/Books: https://zerotofinals.com/books/The audio in the episode was expertly edited by Harry Watchman.

What should you do if you have an autoimmune flare?Whether you have rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, gout, lupus, or another inflammatory condition, a flare can be painful and discouraging—but it doesn't necessarily mean your treatment has failed.The goal in rheumatology is always full remission, and understanding your flares helps you and your rheumatologist make the best treatment decisions.If you're living with rheumatoid arthritis (RA), psoriatic arthritis, ankylosing spondylitis, gout, lupus, vasculitis, Sjögren's syndrome, or another autoimmune disease, this video will help you better understand what to do when symptoms suddenly worsen.

Turning 18 doesn't mean that a young person is suddenly ready to manage a lifelong illness alone. Between 25 and 75 percent of young people with rheumatic diseases experience a gap in care or are lost to follow-up after moving into the adult system — even though most will require ongoing treatment and monitoring.Join pediatric rheumatologist Dr. Michelle Batthish as she chats with our hosts Dr. Janet Pope and Dr. Daniel Ennis about why transition should be a gradual process rather than a single transfer of care.They explore how clinicians can assess readiness, help patients become more independent with appointments and medications, and support parents as their role changes. They also discuss young-adult rheumatology (YARD) clinics, the reasons patients are lost to follow-up, and the importance of addressing mental health, relationships, and the other pressures facing young adults.Dr. Michelle Batthish is a pediatric rheumatologist at McMaster Children's Hospital and associate professor of pediatrics at McMaster University. She is a CanChild scientist and chairs the Canadian Rheumatology Association's Transition Working Group. Her research focuses on healthcare transition and quality improvement in pediatric rheumatology.Dr. Daniel Ennis is a rheumatologist and clinical faculty member in the Division of Rheumatology at the University of British Columbia.Dr. Janet Pope is a professor of medicine at Western University and division head of rheumatology at St. Joseph's Health Care London. Her research focuses on systemic sclerosis, lupus and rheumatoid arthritis.Around The Rheum is produced by the CRA Communications Committee. A special thank you to the podcast team, Dr. Dax G. Rumsey (CRA Communications Committee Chair), Dr. Daniel Ennis (Host), Dr. Janet Pope (Host), David McGuffin of ExploreProductions.ca and Erin Stewart (CRA) for leading production.Our theme music was composed by Aaron Fontwell.For more on the work of the Canadian Rheumatology Association, visit rheum.ca

Drawing from their own lived experiences, they discuss everything from when to disclose a diagnosis while dating to navigating rejection, communicating with partners, managing physical intimacy, and recognizing relationship red flags. They also share practical advice for building healthy partnerships rooted in honesty, empathy, and mutual support. Along the way, Cheryl and Eileen examine what research tells us about chronic illness, loneliness, and relationship outcomes, while challenging the myth that arthritis inevitably harms romantic relationships. Instead, they argue that although chronic illness can create real challenges, it can also deepen connection, vulnerability, and resilience with the right partner. Above all, they emphasize that the strongest foundation for any relationship is cultivating self-compassion, self-worth, and a healthy relationship with yourself first. Episode at a glance: 00:00 Welcome and Premise 00:33 Why This Topic Matters 01:02 Eileen and Cheryl Backgrounds 03:05 When to Disclose Illness 06:26 Cheryl Dating Lessons 10:36 Myth vs Fact Impact 12:56 Self Love and Breaks 18:34 Sex and Intimacy Tips 27:28 Relationship Styles That Work 30:30 Loneliness and Health Research 34:19 Key Takeaways and Wrap Up Medical disclaimer:  All content found on Arthritis Life public channels (including Rheumer Has It) was created for generalized informational purposes only. The content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Episode Sponsors Rheum to THRIVE, an online course and support program Cheryl created to help people with rheumatic disease go from overwhelmed, confused and alone to confident, supported and connected. See all the details and join the program or waitlist now!  Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Hosted by Julie Begum, this podcast explores an MDT conversation on ways to support people experiencing a flare. The conversation covers:How a flare, one of the commonest reasons for contacting the advice line, can be managedSelf-management advice that patients in a flare can be given during a telephone consultationContributors include Ailsa Bosworth MBE, Jade Skeates and Prof Samantha Hider and this podcast on Flare Management forms part of the wider BSR Nurse Advice Line learning resources.   Thanks for listening to Talking Rheumatology! Join the conversation on X using #TalkingRheum or tweet us @RheumatologyUK.BSR is the UK's leading specialist medical society for rheumatology and MSK health professionals. To discover how we can support you in delivering the best care for your patients, visit our website.

Can you exercise if you have rheumatoid arthritis, chronic pain, or an autoimmune disease?In this Rheumatology 101 conversation, Dr. Isabelle Amigues is joined by pediatrician, running coach, and founder of Mindful Marathon, Dr. Michelle Quirk, to debunk one of the biggest myths about exercise and chronic pain.You'll learn:✔️ Why exercise is one of the best treatments for inflammatory arthritis✔️ The biggest myth keeping people with chronic pain from moving✔️ How to safely start exercising—even if you're starting from the couch✔️ Why walking may be the perfect first step✔️ How running can improve heart health, mood, sleep, and inflammation✔️ The connection between exercise, autoimmune disease, and longevity✔️ Why consistency matters more than intensityIf you've been avoiding exercise because you're afraid it will damage your joints, this episode may completely change how you think about movement.At UnabridgedMD, our mission is to help patients achieve remission through evidence-based medicine, education, and hope.

Join Professor Peter Nash from the Griffith University in Brisbane, and Laura Coates, Professor at the University of Oxford's Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, as they discuss a recent paper ‘Ixekizumab with tirzepatide achieved greater disease control than ixekizumab alone in adults with psoriatic arthritis and overweight or obesity: Results from a randomized clinical trial'.

In this updated introduction, I share how my response to this question has changed, the importance of exploring internalized ableism, and why I think a better question is: Can I build a joyful, meaningful life with rheumatoid arthritis along for the ride? After these reflections, you'll hear the original 2021 episode and see what has changed, and what has stayed the same in my thinking over the years. This is very much informed by the rich discussions I've had with people in the Rheum to THRIVE communities and the Arthritis Life community at large, whether on social media, email or in person. I would love to hear your thoughts on this question after listening to the episode!  Episode at a Glance 2026 updated thoughts: 00:00 Why Revisit Normal 02:16 Redefining Normal Life 06:05 Ableism And New Goals 08:50 Acceptance Not Giving Up 17:24 Thriving Without Remission 19:28 Toolboxes Fixing And Adapting 22:22 Community And Imperfection 2021 original audio:  26:08 Origins Of The Question 29:43 “Normal Compared To What?” 33:25 Uncertainty And Remission Paths 34:44 Truth Bombs And New Normal 41:43 Pain Versus Suffering 44:34 ACT In Practice 50:43 Rheum To THRIVE Framework 53:22 Final Takeaways Medical disclaimer:  All content found on Arthritis Life public channels was created for generalized informational purposes only. The content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Episode Sponsors Rheum to THRIVE, an online course and support program Cheryl created to help people with rheumatic disease go from overwhelmed, confused and alone to confident, supported and connected. See all the details and join the program or waitlist now! Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Dr. Hoffman continues his conversation with Dr. David Chernoff, Chief Medical Officer of Setpoint Medical.

Dr. David Chernoff, Chief Medical Officer of Setpoint Medical, discusses electrically driven vagus nerve stimulation (VNS) as a “neuroimmune modulation” approach to autoimmune and inflammatory disease. Chernoff explains the vagus nerve's sensory role in monitoring organs and signaling the brainstem and spleen to regulate immune responses, and how precise stimulation can reduce pro-inflammatory cytokines without immunosuppression. Setpoint's miniaturized, wireless, MRI-compatible implant is placed in an outpatient 45-minute neck procedure and delivers one minute of daily stimulation titrated to an upper comfort level; long-term safety is supported by prior surgical experience and a 242-patient blinded RA study with two-year data, leading to FDA approval for rheumatoid arthritis. The discussion covers add-on use with medications, potential steroid tapering, reimbursement, and research in Crohn's disease, relapsing MS (vision and remyelination), and other conditions, including psoriatic arthritis, lupus, and neurodegenerative diseases.

En este episodio de la Serie de Expertos de la Fundación de Lupus de América, nos centramos en las nuevas guías de tratamiento para el lupus eritematoso sistémico (LES) publicadas por el Colegio Americano de Reumatología (American College of Rheumatology). Nuestro invitado, el Dr. Jorge Sánchez-Guerrero, explica la importancia de estas guías para ofrecer recomendaciones basadas en evidencia orientadas a una atención personalizada del paciente, así como el proceso de elaboración y actualización de dichas guías y los cambios clave que priorizan un control óptimo de la enfermedad y la reducción del uso prolongado de corticosteroides. El Dr. Sánchez-Guerrero destaca la necesidad de la participación activa del paciente y de una buena comunicación con los profesionales de la salud para garantizar un manejo eficaz del lupus. Regístrate para recibir correos electrónicos de la Fundación de Lupus de América (LFA) cuando se publiquen nuevos episodios (en inglés): https://support.lupus.org/site/SPageNavigator/email_subscribe_expert_series.html?s_src=lupus.org&s_subsrc=TES_s9e4Conclusiones:Las nuevas directrices sobre el lupus hacen hincapié en lograr la remisión de la enfermedad y reducir el uso de esteroides para prevenir efectos secundarios irreversibles.Las directrices de tratamiento son recomendaciones, no obligaciones, y respaldan — en lugar de sustituir — el criterio clínico de su médico.El tratamiento debe adaptarse a las necesidades individuales del paciente y a las manifestaciones de la enfermedad.Las terapias biológicas e inmunosupresoras pueden ayudar a controlar la actividad de la enfermedad.La comunicación abierta y la participación activa del paciente son fundamentales para tomar decisiones eficaces sobre el tratamiento.Recursos relacionados:Pregúntele a una educadora de la salud: https://www.lupus.org/es/care-support/ask-a-health-educatorEl Centro Nacional de Recursos sobre el Lupus: https://www.lupus.org/es/resourcesEncuentra apoyo cerca de ti (en inglés): https://www.lupus.org/es/support-groupsNuevas directrices para el tratamiento del lupus (en inglés): https://rheumatology.org/press-releases/new-lupus-sle-clinical-practice-guidelines-released

How can independent rheumatology practices succeed in an increasingly challenging healthcare environment? Hosts Heather and Matthew welcome Mike Chavez and Ray Waldrop, Co-Founders of The Leaders Rheum, to discuss the challenges facing rheumatology practices, including workforce shortages, rising costs, and increasing payer pressures. We also explore how independent practices are leveraging technology and collaborative business models to improve operations while maintaining physician autonomy. Tune in for a look at how The Leaders Rheum is empowering rheumatology practices for long-term success!

What is actually driving the rise in autoimmune disease?    In today's episode, Haylie Pomroy is joined by Dr. Marc Kesselman, Chair of Internal Medicine and Chief of Rheumatology at Nova Southeastern University, to dig into the hidden drivers of autoimmune disease and what patients can actually do about them.   Dr. Kesselman breaks down how COVID-19, vaccine adjuvants, environmental toxins, gut microbiome imbalance, and Epstein-Barr virus all contribute to the rising wave of autoimmune conditions. He explains why non-celiac gluten sensitivity is real even when tests come back negative, how food rotation and plant diversity help protect the microbiome, and why autoantibodies can appear in the bloodstream 15 to 20 years before a single symptom shows up.   He also covers a piece of the autoimmune conversation that most patients never hear: why chronic inflammation significantly raises cardiovascular risk even when cholesterol looks normal, and which tests can catch it before it becomes a crisis.   If you have been told your labs are fine but something still feels wrong, this episode is for you. Tune in to Fast Metabolism Matters.   If your body feels like it's running on empty, overburdened, or just not responding the way it used to, Haylie's latest book, Toxic Overload, tells you exactly what to do. Download your free digital copy today and start understanding what your body is trying to tell you.   Free Download: Get Your Copy of Toxic Overload

Host: Marshall Miller Guest: Ami R. Patel From fracture liaison services to menopause care, the 2026 Interdisciplinary Symposium on Osteoporosis (ISO) covered the latest advances and interdisciplinary strategies in bone health. Join Marshall Miller and Ami Patel, Vice President of Science and Education at the Bone Health and Osteoporosis Foundation, for a recap of this year's meeting.

This episode's Community Champion Sponsor is Ossur. To learn more about their ‘Responsible for Tomorrow' Sustainability Campaign, and how you can get involved: CLICK HEREEpisode Overview: Mobility is foundational to life itself, yet musculoskeletal conditions quietly rob millions of people of the very movement that makes living worthwhile.Dr. Bryan Kelly, President and CEO of HSS, is leading a bold answer to that challenge. As the steward of the world's top-ranked orthopedic institution, now embarking on what he calls a Mobility Revolution, Dr. Kelly is expanding HSS far beyond its storied Manhattan campus.Through landmark partnerships with Deerfield Management, General Atlantic, Peloton, and beyond, HSS is building a global platform to unlock mobility for everybody, everywhere.Join us to discover how Dr. Kelly and the HSS team are leveraging cutting-edge innovation, data intelligence, and how his unwavering focus on the patient are redefining musculoskeletal health for generations to come. Let's go!Episode Highlights:HSS, founded in 1863, has grown into a world-leading musculoskeletal ecosystem spanning surgery, research, and rheumatology.Dr. Kelly, originally a music major, found his calling in orthopedics and built the nation's largest hip preservation service at HSS.HSS's bold new vision, "unlock mobility for every body, everywhere," targets the full care continuum from prevention to recovery.HSS is executing a four-concentric-circle growth strategy, physical expansion and a digital platform built on deep musculoskeletal data.Dr. Kelly and Deerfield Management launched a dedicated mobility venture fund targeting $400 million to $1 billion for musculoskeletal innovation.About our Guest:Dr. Bryan Kelly is the President & CEO, Surgeon-in-Chief Emeritus at HSS, which is the world leader in orthopedics, rheumatology and related disciplines. At the core of HSS is Hospital for Special Surgery, the largest academic medical center specialized in musculoskeletal health, founded in 1863. US News & World Report ranks HSS #1 in Orthopedics nationwide (past 16 consecutive years) and as a national leader in Rheumatology and a Best Hospital for Pediatric Orthopedics. HSS leadership spans patient care, research, education and innovation.Dr. Kelly and his more than 5,000 HSS colleagues are dedicated to the purpose of helping people get back to what they need and love to do, better than any other place in the world. To achieve this, he is focused also on advancing HSS as the best place for specialists in musculoskeletal health and all other team members to advance their careers.A world-renowned surgeon, scientist and educator specialized in sports medicine and hip preservation, Dr. Kelly arrived at HSS in 1996 with undergraduate and medical degrees from Brown University and Duke University. He completed his residency and two-year fellowship at HSS, followed by additional fellowships under the direction of Dr. Marc J. Philippon at University of Pittsburgh Medical Center and Dr. Herbert Resch at the Landeskliniken Hospital in Salzburg, Austria. He has spent much time collaborating with Professor Michael Leunig in Zurich, Switzerland and has established an exchange program for hip preservation trainees. Dr. Kelly completed his MBA at NYU Stern School of Business in 2019.Prior to assuming his role as President and CEO in 2023, Dr. Kelly served in several other leadership positions at HSS including Surgeon-in-Chief, Chief of the Sports Medicine Institute, and Chief of the Hip Preservation Service. He has a faculty appointment as Full Professor of Orthopedics at Weill Cornell Medical College and medical staff appointments at HSS and New York - Presbyterian Hospital. He has cared for several sports teams, serving as Head Team Physician for the New York Rangers, Assistant Team Physician for the New York Giants and Orthopedic Consultant for UFC.Over the past 20 years and with over 200 peer reviewed scientific publications, Dr. Kelly has played an instrumental role in the evolution and maturation of the field of hip preservation, which helps people of all ages with non-arthritic hip disorders to maintain mobility and stability. In 2010, he started the Hip Preservation Service at HSS, which is now the nation's largest with a 12-year record of fellowships.Dr. Kelly has a broad range of both clinical and basic science research interests including the development of a clinical outcomes registry; biomechanical studies evaluating conflict patterns in femoroacetabular impingement and techniques in labral refixation; development of synthetic scaffolds for labral reconstruction and cartilage injuries in the hip; and the development of novel surgical techniques for managing soft tissue injuries around the hip joint.More information about HSS can be found at HSS.edu.Links Supporting This Episode: HSS website: CLICK HEREDr. Bryan Kelly LinkedIn page: CLICK HEREHSS LinkedIn page: CLICK HEREMike Biselli LinkedIn page: CLICK HEREMike Biselli Twitter page: CLICK HEREVisit our website: CLICK HERESubscribe to newsletter: CLICK HEREGuest nomination form: CLICK HERE

Did you know doctors are paid systematically less for procedures on female anatomy? (For example, 45% more to biopsy a penis than a vagina). This shocking reality, highlighted by creator René Jay @bornwithadarktan and Dr. Kemi Doll's book A Terrible Strength, is a baked-in structural issue.In this episode of Our Womanity, host Dr. Rachel Pope sits down with urogynecologist Dr. Jocelyn Fitzgerald—the lead researcher behind the landmark study "Price and Prejudice"—to dismantle the financial architecture failing female patients and their specialists.Dr. Jocelyn Fitzgerald, MD is a board-certified urogynecologist and reconstructive pelvic surgeon at UPMC Magee-Womens Hospital in Pittsburgh, and an assistant professor at the University of Pittsburgh. Her clinical work and research span chronic pelvic pain, female sexual dysfunction, pelvic floor disorders, and genitourinary syndrome of menopause. She is a prominent advocate for equity in women's healthcare, famously publishing research detailing the surgical reimbursement inequities embedded within female anatomy billing.Key Conversation Highlights: The RVU Trap: How the Relative Value Unit (RVU) billing system systematically devalues the female body, gynecologic surgery, and non-surgical menopause visits. "Moms of Medicine" Dilemma: Why society expects OBGYNs to constantly absorb uncompensated emotional labor and primary care duties, diluting their specialized surgical value. The Workforce Crisis: Why post-op "ghost towns" and devalued billing are driving a massive OBGYN shortage, with only six states projected to have adequate care by 2040. Beyond "Lady Stuff": Why menopause is a systemic transition overlapping with cardiology, rheumatology, and neurology, demanding interdisciplinary research. The Allderdice Connection: A fun look back at Rachel and Jocelyn's shared feminist upbringing at Taylor Allderdice High School in Squirrel Hill, Pittsburgh."In medicine, if we don't study it and we don't name it, it's not there. It's just treated as 'lady stuff.'" — Dr. Jocelyn FitzgeraldConnect & Listen:Subscribe to Our Womanity on Apple Podcasts or Spotify, and follow Dr. Rachel Pope on Instagram: @DrRachelPope for daily midlife wellness tips!The Study: Price and Prejudice: Reimbursement of Surgical Care on Male Versus Female Anatomies by Madeline Penn, Donessa Colley, Pratistha Koirala, Dr. Louise King, and Dr. Jocelyn Fitzgerald.

Dr. Jack Cush lectures on giving a great presentation; based on 40 years of lecturing in Rheumatology.

Dr. Hazelwood emphasizes the importance of balancing risks and benefits and provides insights into how modern treatments can significantly improve quality of life. The episode emphasizes the safety and necessity of these medications and highlights the benefits of starting treatment early to prevent long-term complications.  This episode is particularly valuable for anyone newly diagnosed with rheumatoid arthritis who is navigating the complexities and concerns surrounding medication. Episode at a glance: Meet Rheumatologist & Researcher Dr. Glenn Hazelwood: Busting Myths About Medications Challenging Stigmas Around Advanced Treatments Addressing Misconceptions About Medication Use Medical disclaimer:  All content found on Arthritis Life public channels (including Rheumer Has It) was created for generalized informational purposes only. The content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Episode Sponsors Rheum to THRIVE, an online course and support program Cheryl Crow, OT created to help people with rheumatic disease go from overwhelmed, confused and alone to confident, supported and connected. See all the details and join the program or waitlist now!  Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Understanding how values and communication styles differ across cultures is key to succeeding internationally. That’s why training in cross-cultural communication has become commonplace in the international business world. In this session, we’ll look at 6 dimensions of cross-cultural communication and their application to medical scenarios.

Mehlman Qbanks: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://qbanks.mehlmanmedical.com/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠IG: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/mehlman_medical/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Main Website: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://mehlmanmedical.com/⁠

What happens at one of the world's largest rheumatology conferences, and why should patients care? In this special episode of The Health Advocates, Steven Newmark is joined by Dr. Shilpa Venkatachalam, Director of Patient-Centered Research at the Global Healthy Living Foundation (GHLF), to discuss the biggest takeaways from EULAR 2026, the annual congress of the European Alliance of Associations for Rheumatology. The conversation explores why conferences like EULAR are so important for advancing patient care, how researchers, physicians, and patient advocates work together to shape the future of rheumatology, and why the patient voice has become an essential part of medical research. Steven and Shilpa also highlight GHLF's contributions to this year's conference, including two original research posters examining barriers to the early recognition of hidradenitis suppurativa and the unmet informational and support needs of people living with Sjögren's disease. Along the way, they discuss exciting emerging trends in rheumatology and clinical care, especially the increasing emphasis on patient-reported outcomes. Whether you're living with a rheumatic disease, caring for someone who is, or simply interested in the future of healthcare, this episode offers an inside look at how today's research is helping shape tomorrow's treatments—and why patient perspectives are more important than ever. Access the GHLF HS Diagnosis Accelerator: https://ghlf.org/hscheck/ Contact Our HostSteven Newmark, Chief of Policy at GHLF: snewmark@ghlf.orgA podcast episode produced by Amelia Violet Prouse, Associate Podcast & Video Producer at GHLF.We want to hear what you think. Send your comments in the form of an email, video, or audio clip of yourself to podcasts@ghlf.orgListen to all episodes of The Health Advocates on our website or on your favorite podcast channel.See omnystudio.com/listener for privacy information.

In this episode of The Brave Enough Show, Dr. Sasha Shillcutt and Dr. Barb Edelheit discuss:  The silent grief of the empty nest  Reclaiming desire, ambition, and agency  Redefining purpose beyond caretaking  Giving yourself permission to want more again  "Not every stage of life is fabulous, and we put a lot of pressure on ourselves as working moms. We can be intentional in the moments of motherhood and enjoy the moments we can, even in the busy years."   Dr. Barb Edelheit    Guest Bio:  Barbara Edelheit, MD, is an accomplished pediatric rheumatologist, educator, and passionate advocate for gender equity in medicine. She serves as an Associate Professor of Pediatrics at the University of Connecticut School of Medicine, where she has made significant contributions to both clinical care and academic leadership. At Connecticut Children's in Hartford, CT, Dr. Edelheit holds several key leadership roles, including Division Head of Rheumatology, past Board Chair of the Connecticut Children's Specialty Group, and Vice President of the Medical Staff. Dr. Edelheit's clinical expertise centers on the diagnosis and treatment of pediatric autoimmune and inflammatory conditions. She earned her medical degree from the State University of New York Upstate Medical University, followed by residency at The New York Presbyterian Hospital – Cornell Medical Center. She then completed her pediatric rheumatology fellowship at the Hospital for Special Surgery. A dedicated mentor and educator, Dr. Edelheit is deeply committed to fostering the next generation of medical professionals. Her leadership extends to promoting women in medicine, most notably through founding and chairing an affinity group for women physicians at Connecticut Children's. She strongly believes in the critical importance of mentorship and sponsorship throughout medical careers. As the National Mentorship Chair for the American Medical Women's Association (AMWA), Dr. Edelheit works to empower women in medicine, advocating for their success and professional growth. She also serves as the faculty mentor for the University of Connecticut's AMWA student chapter, providing guidance and support to medical students pursuing their careers.    Brave Enough 2026 CME Conference: For ten years, women have gathered at the Brave Enough Conference to step away from the demands of medicine and into a space of renewal. This anniversary year, we celebrate a decade of empowerment and sisterhood—ten years of lifting each other up, reigniting purpose, and remembering that none of us has to do this alone. Join us September 24-27, 2026, at the Omni Scottsdale Resort and Spa. Follow Brave Enough:   WEBSITE | INSTAGRAM | FACEBOOK | TWITTER | LINKEDIN Join The Table, Brave Enough's community. The ONLY professional membership group that meets both the professional and personal needs of high-achieving women.

This podcast has been funded by an educational grant from Viatris. Systemic lupus erythematosus (SLE) is a complex, heterogeneous disease shaped by dysregulated immune pathways, variable organ involvement, and substantial patient burden. In this educational podcast, Anca Askanase explores how a deeper understanding of SLE immunology can help rheumatologists contextualize disease activity, evolving research, and guideline-based care. Topics covered: Key immune pathways involved in SLE pathophysiology, including innate and adaptive immune dysregulation  How pathway biology may help explain clinical heterogeneity and differences in disease activity between patients  What rheumatologists should consider when interpreting emerging pathway-based research and cross-disease immunology concepts  How current guideline-based care frames treatment goals, patient burden, and the evolving focus on remission in SLE  Speakers Anca D. Askanase, Chair, Department of Medicine, and Chief, Division of Rheumatology, Hospital for Special Surgery, New York, USA

Drs. Jack Cush & Arthur Kavanaugh, two of rheumatology's most trusted voices, provide a breakdown of the latest breakthroughs and hottest topics in rheumatology from the EULAR 2026 meeting in London.

What actually happens at a major international medical conference — and why should patients care? In this episode of The Health Advocates, Steven Newmark reports from EULAR 2026 in London, one of the world’s largest rheumatology conferences, to explain how meetings like this help shape the future of patient care. The episode explores why conferences matter not just for doctors and researchers, but for patients and advocacy organizations as well. Steven discusses how practicing clinicians learn about the latest medical advances, how researchers connect directly with physicians treating patients every day, and why organizations like GHLF play an important role in bringing real-world patient experiences into scientific and medical conversations. The episode also highlights several emerging themes already generating excitement at EULAR this year, including the growing role of artificial intelligence in rheumatology and the potential future of CAR-T and cell therapies for autoimmune diseases like lupus and rheumatoid arthritis. Most importantly, the conversation explains how scientific innovation ultimately connects back to what matters most: improving the daily lives of patients. Contact Our HostSteven Newmark, Chief of Policy at GHLF: snewmark@ghlf.orgA podcast episode produced by Amelia Violet Prouse, Associate Podcast & Video Producer at GHLF.We want to hear what you think. Send your comments in the form of an email, video, or audio clip of yourself to podcasts@ghlf.orgListen to all episodes of The Health Advocates on our website or on your favorite podcast channel. See omnystudio.com/listener for privacy information.

In the future, can autoimmune disease become curable? A groundbreaking study from Germany suggests there may be a pathway in some cases. Patients with severe, treatment-refractory lupus who received CD19 CAR-T cell therapy have remained in drug-free remission for up to five years without ongoing immunosuppression. In this episode, we discuss how these findings are shifting the conversation from disease control to the possibility of cure, and what they could mean for lupus, inflammatory myopathies, systemic sclerosis, vasculitis, rheumatoid arthritis, and autoimmune diseases more broadly. We also explore CAR-T therapy, immune resets, regulatory T cells, relapse risk, and the future of rheumatology with Dr. Georg Schett. 

Drs. McMahon and Kalunian discuss how the latest lupus nephritis guidelines from the American College of Rheumatology and European Alliance of Associations for Rheumatology are shifting care from short-term, reactive treatment to longer-term, continuous maintenance—often 3 to 5 years or more—to better prevent kidney flares and preserve renal function. They highlight emerging data on biologic-based triple therapy (including belimumab); the importance of biomarkers and repeat biopsies; and the growing push toward personalized, sometimes indefinite, therapy for high‑risk patients.

In this episode, Dr. Proton Rahman reflects on his journey from patient with spondyloarthritis to internationally recognized rheumatologist and newly appointed member of the Order of Canada. He shares how his lived experience shapes his approach to patient care, offering insight into empathy, trust, and connection in chronic disease management.Dr. Rahman also discusses the influence of key mentors — including Dr. Dafna Gladman, herself an Officer of the Order of Canada — in shaping his path into research and his work in the genetics of psoriatic arthritis and beyond! The conversation highlights the shift toward polygenic risk and the ongoing challenge of translating genetic discoveries into clinical practice.Looking ahead, Dr. Rahman explores the future of rheumatology, emphasizing precision medicine, improved diagnostics, and more effective use of existing therapies. A thoughtful discussion on humility, mentorship, and the evolving complexity of modern rheumatology.Dr. Proton Rahman is Clinical Chief of Rheumatology at Newfoundland and Labrador Health Services and John Lewis Distinguished Professor at Memorial University. A global expert in spondyloarthritis and psoriatic arthritis, his research focuses on the genetics of inflammatory arthritis and its translation into improved patient care. He is a recent appointee as a Member of the Order of Canada.Around The Rheum is produced by the CRA Communications Committee. A special thank you to the podcast team, Dr. Dax G. Rumsey (CRA Communications Committee Chair), Dr. Daniel Ennis (Host), Dr. Janet Pope (Host) David McGuffin (exploreproductions.ca),and Erin Stewart (CRA) for leading production.Our theme music was composed by Aaron Fontwell.For more on the work of the Canadian Rheumatology Association, visit rheum.ca

Methotrexate in Rheumatology:Methotrexate is a very old drug and is known to be chemotherapeutic. Let us see how this medication reduces inflammation, alleviates joint pain, and slows down disease progression. We'll see some dosage, administration, and monitoring considerations as well as the benefits of Folic Acid if taken along with Methotrexate. Like, comment and subscribe for more information!Rheumatology 101 by Isabelle Amigues, MD. #healthIf you have rheumatoid arthritis, lupus, gout, or any inflammatory condition — this conversation will change how you think about healing.Hope, driven by science.

Fifty years ago, pediatric rheumatic disease was often marked by disability, limited treatment options, and low expectations for long-term outcomes. In 1976, a small group of clinicians and scientists helped launch a new understanding of immune-mediated disease in children and laid the foundation for modern pediatric rheumatology. In this episode, we explore how the field evolved from managing chronic disability to expecting remission, transforming both treatment and quality of life for children. We also examine the scientific breakthroughs, models of care, and remaining challenges that continue to shape the future of pediatric rheumatology. 

Dr. Jack Cush discusses his favorite journal articles from the past week on RheumNow.com.

Text Dr. Lenz any feedback or questions Beyond the Pain Scale: Using WPI/SSS and FIQR to Measure Fibromyalgia Severity and Treatment ProgressThe script explains that fibromyalgia care often relies too heavily on a 1–10 pain scale, overlooking fatigue, unrefreshed sleep, brain fog, and daily function, which leaves patients feeling unheard and clinicians without clear data. It describes how the American College of Rheumatology shifted from the 1990 tender point exam to revised criteria (2010, refined in 2011 and 2016) using two quick questionnaires: the Fibromyalgia Survey Criteria—Widespread Pain Index (19 pain regions) plus Symptom Severity Score (fatigue, unrefreshed sleep, cognitive symptoms, plus headaches/abdominal pain/depression), combined as the PSD—and the Revised Fibromyalgia Impact Questionnaire (FIQR), a 21-item measure of function, overall impact, and symptoms scored 0–100. Examples show how these tools provide baselines, track change, guide treatment adjustments, and capture clinically meaningful improvement beyond pain alone.00:00 Beyond the Pain Scale01:04 Why Fibro Gets Missed03:36 Old Criteria to New Tools04:30 Two Key Questionnaires05:45 Widespread Pain Index07:49 Symptom Severity Score09:35 Diagnosis and Tracking Baseline10:50 Advocating at Appointments11:22 FIQR Daily Function12:59 FIQR Impact and Symptoms15:51 Meaningful Improvement Benchmarks16:16 Using Both Tools Together19:05 Tracking Life Factors Over Time20:35 Wrap Up and Next StepsClick here for the YouTube Channel  Support the showWhen I started this podcast and YouTube Channel—and the book that came before it—I had my patients in mind. Office visits are short, but understanding complex, often misunderstood conditions like fibromyalgia takes time. That's why I created this space: to offer education, validation, and hope.  If you've been told fibromyalgia “isn't real” or that it's “all in your head,” know this—I see you. I believe you. This podcast aims to affirm your experience and explain the science behind it. Whether you live with fibromyalgia, care for someone who does, or are a healthcare professional looking to better support patients, you'll find trusted, evidence-based insights here, drawn from my 29+ years as an MD.Please remember to talk with your doctor about your symptoms and care. This content doesn't replace per...

What is cultural distress? It is a negative response rooted in a cultural conflict where the patient lacks control over their situation. It results in more physiologic effects on the body resulting in allostatic overload. To prevent this, healthcare practitioners must use strategies such as cultural humility to help patients navigate healthcare. Come find the best ways to deliver culturally sensitive care in any setting.

Rochester was recently ranked the fifth worst American city for allergies. We sit down with members of the Golisano Children's Hospital Pediatric Allergy team to discuss how families can prepare for allergy season. They explain triggers, treatments, and how allergies affect children and schools. In studio: Jessica Stern, M.D., associate professor of allergy and immunology in the Department of Medicine, Division of Allergy/Immunology and Rheumatology; and the Department of Pediatrics, Division of Pediatric Allergy and Immunology at University of Rochester Medicine Katherine L. Tuttle, M.D., clinical director of the Department of Pediatric Allergy and Immunology, associate program director of the Allergy and Immunology Fellowship, and assistant professor of pediatrics and medicine at University of Rochester Medicine ---Connections is supported by listeners like you. Head to our donation page to become a WXXI member today, support the show, and help us close the gap created by the rescission of federal funding.---Connections airs every weekday from noon-2 p.m. Join the conversation with questions or comments by phone at 1-844-295-TALK (8255) or 585-263-9994, email, Facebook or Twitter. Connections is also livestreamed on the WXXI News YouTube channel each day. You can watch live or access previous episodes here.---Do you have a story that needs to be shared? Pitch your story to Connections.

Host: Darryl S. Chutka, M.D.  Guest: Uma Thanarajasingham, M.D., Ph.D.  Systemic lupus is a chronic autoimmune disease with a variety of immunologic and laboratory abnormalities. It has numerous clinical manifestations potentially involving multiple organs. It's known as the great imitator because it can mimic a variety of other diseases, and it's not uncommon for patients to have symptoms for a number of years prior to a diagnosis being established. What symptoms should alert us to the possibility of lupus? What do we do with a low titer, positive ANA? How is a firm diagnosis established and what role does the primary care clinician play in the management of those with lupus? I'll be asking these questions and more of my guest, Dr. Uma Thanarajasingam from the Division of Rheumatology at the Mayo Clinic as we discuss “Lupus Today: Advances in Diagnosis and Treatment”.  Connect with us! Mayo Clinic Talks Podcast Season 6 | Mayo Clinic School of Continuous Professional Development 

Today, we discuss a new guidance statement from the American College of Rheumatology aimed at bringing much-needed structure to the evaluation and management of patients with VEXAS. This episode breaks down key recommendations, including who should be tested, the best approaches to diagnostic evaluation, how to interpret bone marrow findings, and emerging strategies for treatment—offering clarity in a diagnosis that, until recently, was marked by uncertainty. 

Vagus nerve stimulation has been a hot topic in the AiArthritis community, and for good reason. In this episode, host Tiffany sits down with Dr. Vibeke Strand, Adjunct Clinical Professor in the Division of Immunology/Rheumatology at Stanford University, to explore what VNS actually is, what the research shows, and why it could be a game changing option for people who have not found success with traditional treatments.   Whether you have struggled to find a treatment that works or are simply curious about what is emerging in the rheumatology space, this episode shares useful information you can bring to your next doctor's appointment.   NOTE: As of April 2026 this device is only available in the United States. We will keep you updated as it becomes available elsewhere!     Episode Highlights: What VNS is and how it connects to inflammation in AiArthritis diseases How VNS differs from traditional biologics/DMARDs and whether it can be used alongside them What the research says about its effectiveness beyond just pain relief Who might be a good candidate and how to start the conversation with your care team   Links & Resources Have questions about this episode or topics you want to hear us bring to the table? Email us at podcast@aiarthritis.org  Donate to Support the Show: www.aiarthritis.org/donate   Follow AiArthritis on all social media platforms @IFAiArthritis Sign up for our Monthly AiArthritis Voices 360 Talk Show newsletter! HERE   Connect with our Co-Hosts: Tiffany is the CEO at International Foundation for AiArthritis and uses her professional expertise in mind-mapping and problem solving to help others, like her, who live with AiArthritis diseases work in unison to identify and solve unresolved community issues. Connect with Tiffany: Facebook: @tiffanyAiArthritis Twitter: @TiffWRobertson LinkedIn: @TiffanyWestrichRobertson   Dr. Vibeke Strand is an Adjunct Clinical Professor in the Division of Immunology/Rheumatology at Stanford University, where she has taught since 1993, and previously at University of California, San Francisco. Dr. Strand has also served as a consultant in clinical research and regulatory affairs to pharmaceutical and biotech companies since 1991. She has been a clinical rheumatologist for more than 40 years, previously in subspecialty practice in San Francisco, as a clinical investigator, and subsequently senior positions in clinical research at three pharmaceutical/biotech companies before embarking on her consulting practice.   Among her many accomplishments, Dr. Strand has authored over 450 original publications, is a Fellow of the American College of Physicians, and a Master of the American College of Rheumatology.    

Dr. Jack Cush lectures on giving a great presentation; based on 40 years of lecturing in Rheumatology.

Private rheumatology practice is contracting under multi-directional pressure: shrinking margins, escalating prior authorizations, tightening Pharmacy Benefit Managers (PBM) and payer restrictions on drug access, and instability across core revenue streams. At the same time, demand is rising, wait times are surging, and workforce shortages are intensifying—driving clinician burnout and retention challenges.   This episode is about The American College of Rheumatology's response, in expanding its leadership role in advocacy, health policy reform, and workforce development to help private practices move from survival to sustainable growth. 

Eileen and Gittel talk about why they're passionate about leading support spaces, what those groups are really like (spoiler: welcoming, not intimidating), and how connection can make a huge difference. You'll also hear gentle, practical advice for those early days like pacing yourself, adapting as you go, and redefining what it means to thrive. It's a comforting reminder that even with chronic illness, you can still build a full, meaningful life and you don't have to figure it out alone. And if you'd like to join one of the latest Rheum to THRIVE groups, you can do so here.  Episode at a glance: 00:00 Meet the New Facilitators 01:13 Diagnoses and Comorbidities 04:35 Why Eileen Facilitates 08:06 Why Gittel (GT) Facilitates 12:09 Why Support Groups Matter 15:27 Program Structure Highlights 22:43 GT's Teaching Style 23:32 Creating Safe Space 24:28 Alumni Group Exploration 25:46 Eileen's Facilitation Style 33:42 Common Support Group Worries Addressed 37:48 Importance of Diversity In Groups 41:41 Reflections on Thriving With Arthritis Medical disclaimer:  All content found on Arthritis Life public channels was created for generalized informational purposes only. The content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Episode Sponsors Rheum to THRIVE, an online course and support program Cheryl created to help people with rheumatic disease go from overwhelmed, confused and alone to confident, supported and connected. See all the details and join the program or waitlist now!  Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

In this episode of Rheumatology 101, Dr. Isabelle Amigues explores a topic that may be even more powerful than medication: mindset.What's the difference between cure and remission?Can your thoughts influence your healing journey?Why do some patients struggle to tolerate treatment, until something shifts internally?As a board-certified rheumatologist with over 20 years of experience, Dr. Amigues shares real patient stories about rheumatoid arthritis, remission, and the profound impact of belief, worthiness, and emotional readiness on outcomes.She explains:• The difference between remission and cure• Why some patients unconsciously resist healing• How mindset affects medication tolerance• The body–mind communication loop• Why disease may be a message, not an enemy• The affirmation that changed her own health journeyIf you're living with rheumatoid arthritis or any autoimmune condition, this episode offers hope: remission is possible and you deserve it.Repeat with me:I am healthy and alive.

Pericardial Disease is couched between two medical disciplines: Cardiology and Rheumatology, and those with these conditions visit medical professionals viewing their treatment through one lens or the other. This episode addresses the shifting reality that pericarditis and myocarditis are no longer separate silos but rather takes the broader view of inflammatory heart disease. We'll examine how rheumatologists should be thinking about pericardial disease, when we should get involved, how diagnosis and imaging fit in, plus the evolution of treatment. 

The conversation also dives into the emotional side of chronic illness, including fear of movement, the importance of interoception (body awareness), and how to avoid the boom–bust cycle of overdoing it. Cheryl and Jamie reflect on the shift from a “warrior” mindset to one rooted in acceptance, adaptability, and long-term self-care. Ultimately, this episode offers a hopeful, realistic perspective: that thriving with arthritis isn't about pushing harder, it's about finding what works for your body and building a life alongside it, not in spite of it.  Episode at a glance: 01:27 Jamie's Diagnosis Journey 05:41 Processing The Reality Online 07:05 Gender And Community Support 11:50 From Isolation To Teaching 19:12 Why Accessibility Matters 22:59 Adaptations And Safer Strength 31:58 Interoception Explained 33:23 Proprioception and Arthritis 36:02 When Awareness Becomes Sensitivity 36:57 Progression Beyond Rehab Sheets 39:55 Progressive Overload in Flares 42:45 Just Right Challenge 43:09 Accessible Training Tools 45:47 Acceptance and Thriving 48:58 Community and Uncertainty Medical disclaimer:  All content found on Arthritis Life public channels was created for generalized informational purposes only. The content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Episode Sponsors Rheum to THRIVE, an online course and support program Cheryl created to help people with rheumatic disease go from overwhelmed, confused and alone to confident, supported and connected. See all the details and join the program or waitlist now!  Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Support the Institute today. https://givenow.nova.edu/the-institute-for-neuro-immune-medicine-inim-2025 In today's episode, Haylie Pomroy is joined by Dr. Marc Kesselman, Chair and Associate Professor in the Department of Internal Medicine at Nova Southeastern University. Together, they examine autoimmunity through a clinical lens, discuss its higher prevalence in women, and review key laboratory tests that may be considered in the evaluation of autoimmune conditions. Dr. Kesselman further outlines the risks and potential triggers of autoimmunity, the role of nutrition in supporting recovery, and how he helps patients navigate the fear of disease flares through individualized treatment strategies and patient education.  He also emphasizes the importance of monitoring inflammatory markers, fostering a strong patient–provider relationship, and addresses questions from the community. Dr. Marc Kesselman is the chair and associate professor at the Department of Internal Medicine at Dr. Kiran C. Patel College of Osteopathic Medicine. He is also the chief of the Division of Rheumatology at Nova Southeastern University. Dr. Kesselman received his medical degree from Des Moines University College of Osteopathic Medicine and has been in practice for more than 20 years.  LinkedIn: https://www.linkedin.com/in/marc-m-kesselman-d-o-facoi-facc-facr-6491479/    Haylie Pomroy, Founder and CEO of The Haylie Pomroy Group, is a leading health strategist specializing in metabolism, weight loss, and integrative wellness. With over 25 years of experience, she has worked with top medical institutions and high-profile clients, developing targeted programs and supplements rooted in the "Food is Medicine" philosophy. Inspired by her own autoimmune journey, she combines expertise in nutrition, biochemistry, and patient advocacy to help others reclaim their health. She is a New York Times bestselling author of The Fast Metabolism Diet.   Learn more about Haylie Pomroy's approach to wellness through her website: https://hayliepomroy.com   Instagram: https://www.instagram.com/hayliepomroy  Facebook: https://www.facebook.com/hayliepomroy  YouTube: https://www.youtube.com/@hayliepomroy/videos  LinkedIn: https://www.linkedin.com/in/hayliepomroy/  X: https://x.com/hayliepomroy    Enjoy our show? Please leave us a 5-star review on the following platforms so we can bring hope and help to others.   Apple Podcasts: https://podcasts.apple.com/us/podcast/hope-and-help-for-fatigue-chronic-illness/id1724900423   Spotify: https://open.spotify.com/show/154isuc02GnkPEPlWfdXMT   Sign up today for our newsletter. https://nova.us4.list-manage.com/subscribe?u=419072c88a85f355f15ab1257&id=5e03a4de7d    This podcast is brought to you by the Institute for Neuro-Immune Medicine. Learn more about us here.   Website: https://www.nova.edu/nim/ Facebook: https://www.facebook.com/InstituteForNeuroImmuneMedicine Instagram: https://www.instagram.com/NSU_INIM/ Twitter: https://www.twitter.com/NSU_INIM

STEP: Obesity and Inflammation: Weight management in Rheumatology. Dr. Uzma Haque  STEP: Mitigating Risk for Rheumatic Disease Patients Undergoing Orthopedic Surgery. Dr. Susan Goodman

Dr. Jack Cush reviews the regulatory actions, news and journal reports from this past week on RheumNow.com

It is not often that I see a child with possible rheumatologic disease in the pediatric ER. What to ask, what to check for and what labs to order are always important things to think about. That is why I asked Dr. Robert Lowe to come on the show and discuss the management of those patients. Dr. Lowe Advice on Labs to order when suspecting Rheumatological condition: For suspected JIA. Most important to confirm joint swelling on physical exam AND a history of one or more joints being swollen continuously for 6 weeks or longer. Systemic JIA (only 15% of kids with JIA) ESR and CRP are both elevated like you would see with an infection or with inflammatory bowel disease with the added presence of significant joint swelling and daily recurring high fevers (>102F usually) without other symptoms of infection for Systemic JIA. For other systemic autoimmune disease High ESR with normal or near normal CRP can suggest the presence of another systemic autoimmune disease such as SLE D-dimer Ferritin LDH UA with Random protein to Cr ratio Dont order ANA and instead check ONLY the following: ·  Double Stranded DNA (dsDNA) Ab, ·  Smith antibody (not Smooth muscle antibody), ·  Ribonuclear protein Ab (RNP Ab), ·  SSA and SSB Abs (Sjogrens syndrome antibodies)     Please consider contributing to PEM Rules at https://ko-fi.com/pemrules And check out www.pemrules.com  Copyright PEM Rules LLC DISCLAIMER By listening to this podcast, you agree not to use these resources as medical advice to treat any medical conditions in either yourself or others, including, but not limited to, patients that you are treating. Consult your own physician for any medical issues that you may be having. This entire disclaimer also applies to any guests or contributors to the podcast or website. Under no circumstances shall PEM Rules, the PEM Rules podcast or any guests or affiliated entities be responsible for damages arising from their use. This podcast should not be used in any legal capacity whatsoever, including, but not limited to, establishing "standard of care" in a legal sense or as a basis for expert witness testimony. No guarantee is given regarding the accuracy of any statements or opinions made on the website or in the podcast.